- Home
- SNTI vs JCTC Comparison
SNTI vs JCTC Comparison
Compare SNTI & JCTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- JCTC
- Stock Information
- Founded
- SNTI 2016
- JCTC 1953
- Country
- SNTI United States
- JCTC United States
- Employees
- SNTI N/A
- JCTC N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- JCTC
- Sector
- SNTI Health Care
- JCTC
- Exchange
- SNTI Nasdaq
- JCTC NYSE
- Market Cap
- SNTI 19.1M
- JCTC 16.8M
- IPO Year
- SNTI N/A
- JCTC 1996
- Fundamental
- Price
- SNTI $4.67
- JCTC $4.52
- Analyst Decision
- SNTI Strong Buy
- JCTC
- Analyst Count
- SNTI 1
- JCTC 0
- Target Price
- SNTI $12.00
- JCTC N/A
- AVG Volume (30 Days)
- SNTI 115.8K
- JCTC 9.3K
- Earning Date
- SNTI 11-14-2024
- JCTC 01-14-2025
- Dividend Yield
- SNTI N/A
- JCTC N/A
- EPS Growth
- SNTI N/A
- JCTC N/A
- EPS
- SNTI N/A
- JCTC N/A
- Revenue
- SNTI N/A
- JCTC $46,606,336.00
- Revenue This Year
- SNTI $11.52
- JCTC N/A
- Revenue Next Year
- SNTI $78.57
- JCTC N/A
- P/E Ratio
- SNTI N/A
- JCTC N/A
- Revenue Growth
- SNTI N/A
- JCTC N/A
- 52 Week Low
- SNTI $1.52
- JCTC $3.86
- 52 Week High
- SNTI $16.94
- JCTC $5.88
- Technical
- Relative Strength Index (RSI)
- SNTI 56.65
- JCTC N/A
- Support Level
- SNTI $3.72
- JCTC N/A
- Resistance Level
- SNTI $4.93
- JCTC N/A
- Average True Range (ATR)
- SNTI 0.46
- JCTC 0.00
- MACD
- SNTI 0.01
- JCTC 0.00
- Stochastic Oscillator
- SNTI 81.82
- JCTC 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About JCTC JEWETT-CAMERON TRADING CO
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.